扫码关注科兴官方微信号“疫苗之益”

COVID-19 Vaccine (Vero Cell), Inactivated - CoronaVac®
COVID-19 Vaccine (Vero Cell), Inactivated - CoronaVac®

Conditioned market authorization in China on February 5, 2021


           l  The results of pre-clinical and clinical research trials were published in Science and The Lancet.

           l The Phase Ⅲ and real-world studies conducted in some other countries showed that  CoronaVac® is safe for adults at all ages ≥ 18. It also showed  a significant effect on reducing the incidence, hospitalization and death rate caused by COVID-19 infection.

           lThe inactivated COVID-19 Vaccine, CoronaVac®, was recommended under WHO Emergency Use Listing (EUL).

           l  The annual production capacity is over 2 billion doses, and the vaccine has been approved to use by more than 40 countries around the world.

Related news
year:
--All--
  • --All--
  • 2021
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
Load more